Overview of TIP819: Lifco AB (LIFCO-B.ST) with Kyle Grieve & Shawn O'Malley
This episode examines Lifco AB, a Swedish serial acquirer with more than 275 acquisitions across niche industrial and medical markets. Kyle Grieve and Shawn O’Malley argue that Lifco is a high-quality compounding machine: it has delivered strong earnings growth since its IPO, maintained zero shareholder dilution, generated robust free cash flow, and kept capital allocation highly disciplined. The discussion focuses on how Lifco’s decentralized acquisition model, niche-market focus, and unusual compensation structure have helped it compound value for years.
What Lifco Does
Lifco is not a software aggregator like Constellation Software. Instead, it buys and holds small to mid-sized niche businesses in industrial and healthcare-adjacent markets, with an emphasis on:
- Cash-flow-positive businesses
- Market leaders in narrow niches
- Long-term ownership, not quick flips
- Minimal reliance on large customers or suppliers
- Businesses that can remain strong for decades
The company operates through three main segments:
Dental
- Supplies consumables, equipment, and technical services to dentists
- Mostly Europe-focused, with some U.S. exposure
- Stable and defensive, with margins around 21%+
- Includes some software exposure, but it is very small
Demolition and Tools
- Includes niche equipment like demolition robots and specialized attachments
- Example: Brock, which reportedly has ~70% share in a small global demolition robot market
- Higher margin but more cyclical and tied to construction/infrastructure activity
Systems and Solutions
- Lifco’s largest segment by revenue
- Includes contract manufacturing, environmental tech, infrastructure products, special products, and transportation products
- Strong margins and fast growth
- Management has begun separating some divisions into new reporting buckets due to their scale and differences
Why the Model Works
The hosts emphasize that serial acquisition sounds difficult in theory because it requires repeatedly buying private businesses at good prices while convincing founders to sell. Lifco succeeds because it offers a strong win-win:
- Sellers get liquidity and continuity
- Lifco gets good businesses at reasonable prices
- Subsidiaries keep management autonomy
- The mothership provides capital, expertise, and a reputation for long-term stewardship
A major theme is that reputation compounds. Because Lifco is known for treating sellers well and not gutting businesses after acquisition, more quality sellers may prefer selling to Lifco over a private equity buyer.
Acquisition Criteria and Deal Structure
Lifco’s acquisition process is highly disciplined and unusually explicit. Key filters include:
- Niche market leaders
- Sustainable, durable businesses
- Low dependency on a single supplier or customer
- Good working conditions and ethical standards
- Avoidance of industries such as weapons, alcohol, tobacco, fossil fuels, uranium, adult content, gaming, and more
How They Incentivize Sellers and Management
Lifco often uses put/call options rather than stock-based earnouts:
- Sellers get a put option to sell minority shares later at a preset formula
- Lifco gets a call option to buy those shares
- Pricing is tied to future earnings, helping align incentives
- The structure is not dilutive to shareholders
- Exercise is funded with cash or debt, not equity issuance
The episode highlights this as a clever way to preserve alignment without shareholder dilution.
Capital Allocation and Financial Strength
A big part of Lifco’s appeal is its capital efficiency and conservative balance sheet management.
Key financial traits
- Earnings growth since IPO: about 14% annually
- Total return since IPO: about 15% annualized including dividends
- Free cash flow per share growth: around 23% CAGR
- Capex: only 1%–2% of sales, surprisingly low for a company with manufacturing exposure
- Net debt/EBITDA target: 2x–3x, with Lifco typically staying below that range
Why capex stays low
Even though Lifco has “manufacturing” businesses, many are closer to assembly businesses than heavy industrial manufacturers, so they don’t require large reinvestment into machinery or factories.
Capital efficiency metric
Lifco uses ROCE/“ROSE”:
- EBITDA before acquisition costs divided by capital employed
- Reported ROCE is above 20%
- The hosts note that goodwill-adjusted versions can look artificially high and may be less meaningful
Management and Governance
The episode strongly credits management quality as a major driver of Lifco’s success.
Historical leadership
- Carl Bennett helped shape the firm’s DNA through disciplined capital allocation
- Frederick Carlson helped drive major margin expansion and decentralized operating culture
- Carlson reportedly bought more shares after being removed as CEO, showing strong conviction
Current CEO: Per Waldemarsson
- Age 49, with a long internal history at Lifco
- Has held roles at Brock, in the dental division, and as deputy CEO
- Since becoming CEO in 2019, he has overseen strong capital allocation results
- The hosts view him as a capable long-term steward
Ownership and compensation
- Carl Bennett owns roughly 50% of shares and 69% of voting rights
- Other insider ownership is modest
- Executive compensation is tied to:
- Earnings
- Volume growth
- Working capital
- Free cash flow
- Executives and directors receive synthetic options, not traditional dilutive stock options
Moat and Competitive Advantages
The hosts are careful not to overstate a traditional moat, but they identify several durable advantages:
- Process discipline in deal selection and integration
- Strong reputation among sellers
- Decentralized structure that preserves local knowledge
- Focus on micro-niches where large competitors often won’t bother competing
- Ability to support subsidiaries with lower-cost financing and internal expertise
- A portfolio of niche businesses that can function like “micro-monopolies”
A major point: many of Lifco’s target markets are too small to attract large-scale competition, so niche leadership can persist for long periods.
Segment Performance and Cyclicality
The discussion breaks down growth by segment:
- Dental: slowest grower, but most stable
- Demolition and Tools: more cyclical and currently facing weakness
- Systems and Solutions: fastest growing, strongest cash-flow engine
COVID resilience
Lifco performed well during the pandemic:
- Revenue down only 0.5%
- Cash flow margins up 1.5%
- EPS up 11%
This was presented as evidence of the durability of the model.
Main Risks
The main risks discussed were:
1. Acquisition quality
If Lifco overpays or buys weaker businesses, returns could deteriorate.
2. Scale/law of large numbers
As the company grows, it becomes harder to find acquisitions that move the needle.
3. Centralization risk
The company’s decentralized structure is a strength; moving toward centralization could hurt performance.
4. Cyclicality
The demolition and tools division is exposed to:
- Construction
- Infrastructure spending
- Forestry capex
5. Capital allocation discipline
Serial acquirers fail when they start chasing deals for the sake of deploying capital.
Valuation and Scenario Analysis
The episode closes with a three-part valuation framework.
Base case
Assumptions:
- Organic growth: ~4% tapering to 3%
- M&A growth: enough to produce ~10%–12% top-line growth
- EBITDA margin expansion from ~22.5% to ~23.5%
- Exit multiple: 24x EBITDA
- No dilution
Result:
- Estimated value: 580 SEK
- Implied return: about 16% CAGR
- With dividend: about 17%
Bear case
Assumptions:
- Organic growth: ~2%
- M&A growth: ~8%–10%
- Margins drift slightly lower
- Exit multiple: 20x EBITDA
Result:
- Estimated value: 365 SEK
- Implied return: about 6%
- With dividend: about 7%
Bull case
Assumptions:
- Organic growth: ~4%
- Top-line growth: ~12%–14%
- EBITDA margin expands to 25%
- Exit multiple: 27x EBITDA
Result:
- Estimated value: 788 SEK
- Implied return: about 24%
- With dividend: about 24%+
Portfolio Takeaway
The hosts end up constructive on Lifco, though not yet fully committed to making it a large position. Their general view:
- Lifco is a high-quality compounding business
- It has a long runway for acquisitions in Europe’s massive SMB market
- Its governance, incentives, and discipline are unusually strong
- The main hesitation is valuation and the risk that future growth could slow as the company scales
They suggest Lifco could be appropriate as a small portfolio position rather than a full-size holding.
Memorable Quote
“The big plus for a serial acquirer with high EBITDA growth is they release cash flow. Basically, the best thing would be if only we had EBITDA growth because sales growth eats cash.”
Bottom Line
Lifco is presented as a standout serial acquirer with:
- Exceptional historical compounding
- Strong decentralized governance
- Low capex and high cash generation
- No shareholder dilution
- A long runway of niche acquisition opportunities
The key question going forward is not whether the model has worked, but whether Lifco can keep finding high-quality niches and maintain discipline as it continues to scale.